Stephen Berenson
Chairman bei SERES THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Stephen A.
Berenson is currently the Chairman at Seres Therapeutics, Inc., Cellarity Inc., and Repertoire Immune Medicines, Inc. He is also an Independent Non-Executive Director at Moderna, Inc. and a Director at Flagship Pioneering.
Additionally, he serves as a Trustee at The Mahaiwe Performing Arts Center.
Previously, he held the position of Vice Chairman-Investment Banking at 09143628 Ltd.
from 2005 to 2017.
He also served as a Director at ModernaTX, Inc. and CIBO Technologies, Inc. Mr. Berenson obtained his undergraduate degree from the Massachusetts Institute of Technology in 1982.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MODERNA, INC.
0,01% | 07.03.2024 | 21 471 ( 0,01% ) | 2 Mio $ | 31.03.2024 |
SERES THERAPEUTICS INC
0,00% | 04.04.2024 | 3 589 ( 0,00% ) | 2 778 $ | 31.03.2024 |
Aktive Positionen von Stephen Berenson
| Unternehmen | Position | Beginn |
|---|---|---|
| MODERNA, INC. | Director/Board Member | 01.10.2017 |
| SERES THERAPEUTICS, INC. | Chairman | 12.12.2019 |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 14.06.2017 |
| The Mahaiwe Performing Arts Center | Director/Board Member | - |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Chairman | 01.07.2021 |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Director/Board Member | 01.05.2021 |
Ehemalige bekannte Positionen von Stephen Berenson
| Unternehmen | Position | Ende |
|---|---|---|
| 09143628 Ltd. | Corporate Officer/Principal | 01.04.2017 |
CiBO Technologies, Inc.
 CiBO Technologies, Inc. Packaged SoftwareTechnology Services CiBO Technologies, Inc. is a science-driven software company which engage sin the modelling and simulation of agricultural ecosystems. The firm offers CIBO and CIBO Plus software products. The company was founded by Ignacio Bemposta Martinez and Bruno Basso in 2015 and is headquartered in Cambridge, MA. | Director/Board Member | - |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Ausbildung von Stephen Berenson
| Massachusetts Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SERES THERAPEUTICS, INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Health Technology |
CiBO Technologies, Inc.
CiBO Technologies, Inc. Packaged SoftwareTechnology Services CiBO Technologies, Inc. is a science-driven software company which engage sin the modelling and simulation of agricultural ecosystems. The firm offers CIBO and CIBO Plus software products. The company was founded by Ignacio Bemposta Martinez and Bruno Basso in 2015 and is headquartered in Cambridge, MA. | Technology Services |
| The Mahaiwe Performing Arts Center | |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Commercial Services |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Health Technology |
| 09143628 Ltd. | Finance |
